Recent Press Releases

SYSPRO ERP Key to Pharma Co's Focus on Quality, FDA Compliance, Customer Service

SYSPRO ERP Key to Pharma Co's Focus on Quality, FDA Compliance, Customer ServiceSYSPRO Enabling BioVectra Management To Access Vital Data, Tighten Controls Burnaby, British Columbia (Vocus) November

AstraZeneca PLC AZN Third quarter & nine months results

London, 28 October 2010 Revenue for the third quarter declined by 2 percent at constant exchange rates (CER) to $7,898 million. -Strong double-digit sales growth at CER for Crestor, Symbicort and

Sanofi-Aventis Resilient Sales and Business EPS(1) in Q3 2010

PARIS, Oct 28, 2010 /PRNewswire via COMTEX/ -- Change on Q3 2010 a Change at ------- reported

Novartis delivers excellent performance in third quarter

Novartis delivers excellent performance in third quarter: recently launched products generate 20%* of sales; Gilenya approved; Alcon consolidated Basel, Switzerland, Oct 21, 2010 (Thomson Reuters ONE

GlaxoSmithKline PLC (GSK) - 3rd Quarter Results

GlaxoSmithKline PLC (GSK) - 3rd Quarter Results RNS Number : 7760UGlaxoSmithKline PLC21 October 2010 Issued: Thursday, 21st October 2010, London, U.K. Results announcement for the third quarter 2010

Roche Group posts solid sales growth in first nine months

Roche Group posts solid sales growth in first nine monthsFurther market share gains for Roche Diagnostics; Group confirms full-year outlook Group sales increase 2% in local currencies (-1% in Swiss

Watson Signs Exclusive Agreement to Distribute Authorized Generic Concerta(R)

Watson Signs Exclusive Agreement to Distribute Authorized Generic Concerta(R) MORRISTOWN, N.J., Nov. 2, 2010 /PRNewswire via COMTEX/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI) today announced that

Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference

NEW YORK, Nov. 3, 2010 /PRNewswire-FirstCall/ -- Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a presentation by Olivier Brandicourt, President

Medco Delivers Record Third-Quarter 2010 GAAP Diluted EPS of $0.85; Record Diluted EPS Excluding Amortization of Intangible Asse

Medco Delivers Record Third-Quarter 2010 GAAP Diluted EPS of $0.85; Record Diluted EPS Excluding Amortization of Intangible Assets From the 2003 Spin-off of $0.91Raises and Narrows 2010 EPS

Lilly CEO Calls for a 'Wave of Invention' to Reduce the Toll of Diabetes

Lechleiter Addresses the Cleveland Clinic Medical Innovation SummitCLEVELAND, Nov. 3, 2010 /PRNewswire/ -- In a speech to the Cleveland Clinic Medical Innovation Summit, John C. Lechleiter, Ph.D.,

ARCHITECT HIV Ag/Ab Combo Test Wins Prestigious Chicago Innovation Award

Fifth Innovation Award for Abbott in Seven Years Recognizes Innovative Test for Earlier Detection of HIVABBOTT PARK, Ill., Nov. 3, 2010 /PRNewswire/ -- Abbott today announced it has received a 2010

Reportlinker Adds Biomarkers in Cancer Research - High Unmet Need in Cervical Cancer and Lung Cancer to Drive Growth

NEW YORK, Nov. 3, 2010 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Biomarkers in Cancer Research - High Unmet Need in Cervical Cancer

Reportlinker Adds Multiple Sclerosis Drug Discoveries: what the future holds

NEW YORK, Nov. 3, 2010 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Multiple Sclerosis Drug Discoveries: what the future holds

Simcere and Bristol-Myers Squibb Enter Innovative Partnership to Develop Early-Stage Oncology Compound

NANJING, China and PRINCETON, N.J., Nov. 3, 2010 /PRNewswire-Asia/ -- Bristol-Myers Squibb Company (NYSE: BMY) and Simcere Pharmaceutical Group (NYSE: SCR), a leading pharmaceutical company in China,

Rheumatoid Arthritis Patient Share of Actemra Projected to Exceed Patient Share of Cimzia and Simponi Among the Medicare Populat

EXTON, Pa., Nov. 3, 2010 /PRNewswire/ -- Bio-Trends is pleased to announce the publication of a new syndicated report, TreatmentTrends®: Rheumatoid Arthritis Q3 2010. This report covers the use of

For the Treatment of Psoriatic Arthritis, Abbott/Eisai's Humira Has Emerged as the Market Leader, Garnering Sales of More Than $

Through 2019, UCB/Otsuka's Cimzia and Centocor Ortho Biotech/Janssen-Cilag's Stelara Will Contribute Only Modestly to Market Expansion, According to Findings from Decision ResourcesBURLINGTON, Mass.,

Simcere and Bristol-Myers Squibb Enter Innovative Partnership to Develop Early-Stage Oncology Compound

PRINCETON, N.J. & NANJING, China--(BUSINESS WIRE)-- Bristol-Myers Squibb Company (NYSE: BMY) and Simcere Pharmaceutical Group (NYSE: SCR), a leading pharmaceutical company in China, today

CVS Caremark Reports Third Quarter Financial Results

Third Quarter Year-Over-Year Highlights:WOONSOCKET, R.I., Nov. 3, 2010 /PRNewswire-FirstCall/ -- CVS Caremark Corporation (NYSE: CVS), today announced revenues, operating profit, and net income for